Akceso Advisors elects Seng Chin Mah as board member
Akceso Advisors AG appointed Dr. Seng Chin Mah, a 30+‑year pharma executive and BioVersys chair, to strengthen its market-access and regulatory advisory services.
Why it mattersBioVersys and Novartis regulatory experience strengthens Akceso Advisors' Swiss market-access advice for partnership decisions.